Tagged with:

Browse by tag

Innovation

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections, where invasive surgery like organ transplants can’t be performed because it’s too risky, and where hospital wards are breeding grounds for disease.

Innovation

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

As science evolves we are learning that the immune system does so much more than protect us from an outside attack.

Innovation

Rare diseases: Q&A with Martin Andrews

Martin Andrews leads our Rare Diseases Unit to help advance the treatment of patients affected by rare diseases. He was appointed Senior Vice President, GSK Rare Diseases in November 2013.

Innovation

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Innovation

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Innovation

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Innovation

Data transparency

We have a long-standing commitment to data transparency.

Innovation

Can an iPhone transform the way we monitor and improve patient health?

Since 2014, we’ve been transforming the way we do research using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

Innovation

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Innovation

Epigenetics: turn-ons and turn-offs

In the words of the author and biochemist Isaac Asimov, "The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!', but 'That's funny…'"

Innovation

Inside the open lab

"The biggest surprise for me was the openness,” says Thulasi Warrier. “I thought I would be put in a cubicle and not encouraged to speak.”

Innovation

Scientists or detectives? Seeking new clues in COPD

We continuously strive for new opportunities to evolve our understanding of COPD that will help us meet individual patient needs.

Innovation

The race to richer data in clinical trials

That’s why we’re working with a range of partners, including the McLaren Technology Group and Medidata, to find new ways to use biosensors and mobile health platforms to improve patient care.

Innovation

Cell and gene therapy: a new era of medicine

Since the structure of DNA was discovered by James Watson and Francis Crick in 1953, significant advances have been made in our understanding of diseases caused by faulty genes.

Innovation

On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.

How we do business

Evolving our graduated approach to intellectual property

In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.

Innovation

Take a deep breath - your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity

Back to top